Ozempic and other glucagon-like peptide-1 (GPL-1) agonist medications accounted for 10% of the state employee health plan’s ...

There’s usually a sneezing and coughing kid tucked into bed who is aided by a caring mother who offers a dose of a cold syrup ...

The Swiss pharmaceutical company invests in a PTC Therapeutics program to develop treatment for Huntington’s disease.

Trump’s plans to slap tariffs on imported goods from overseas could have a negative impact on the medical devices industry, ...

The ER wasn’t very busy when they arrived at 10:48 p.m., Wettstein recalled. Medical records indicate they checked in and she ...

The Denver Broncos legend is once again partnering with Endo to talk about the non-surgical treatment for Dupuytren’s ...

Bhattacharya and O’Neill join Robert F. Kennedy, Dr. Mehmet Oz, Dr. Martin Makary, former Rep. Dave Weldon and Dr. Janette ...

An unknown number of mothers in Florida have abruptly lost Medicaid coverage after giving birth, despite being eligible, ...

The messages not only help improve HCP-patient interactions but also deliver meaningful business outcomes in point-of-care ...

The Eyes. Lips. Face. Fandom campaign also stars ‘Emily in Paris’ actor Lucien Laviscount to advertise E.L.F.’s Power Grip ...

Intellia Therapeutics received the FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for nexiguran ziclumeran ...

Roche announced it will acquire Poseida Therapeutics in a deal worth up to $1.5 Billion. The deal allows the Swiss company to develop cell therapies in-house. (The Wall Street Journal) Sarepta ...